ACALABRUTINIB

ACALABRUTINIB was reported 12744 times

ACALABRUTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DERMATOPOROSIS 4 0.3333
1 SPLEEN ATROPHY 10 0.1695
2 ORAL MUCOSA HAEMATOMA 6 0.0822
3 ACINETOBACTER SEPSIS 5 0.0781
4 LEUKAEMIC INFILTRATION 10 0.0714
5 RETICULOCYTOPENIA 10 0.0685
6 MANTLE CELL LYMPHOMA RECURRENT 26 0.0598
7 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 36 0.0516
8 HAEMATOTYMPANUM 4 0.0471
9 ORAL BLOOD BLISTER 7 0.0350
10 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 8 0.0348
11 GASTROENTERITIS BACTERIAL 11 0.0333
12 CEREBRAL ASPERGILLOSIS 19 0.0309
13 LEUKOSTASIS SYNDROME 4 0.0301
14 MANTLE CELL LYMPHOMA 45 0.0295
15 BLOOD TEST 5 0.0267
16 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 6 0.0259
17 BLOOD IMMUNOGLOBULIN G ABNORMAL 4 0.0240
18 BLOOD VISCOSITY DECREASED 7 0.0209
19 SPONTANEOUS HAEMATOMA 15 0.0201
20 LYMPHOCYTOSIS 43 0.0200
21 POST PROCEDURAL CONTUSION 6 0.0183
22 PRECANCEROUS CONDITION 12 0.0179
23 WHITE BLOOD CELL COUNT 5 0.0172
24 OLIGODIPSIA 4 0.0171
25 CHRONIC LYMPHOCYTIC LEUKAEMIA 77 0.0162
26 GASTROINTESTINAL LYMPHOMA 4 0.0154
27 EYE HAEMATOMA 4 0.0152
28 MELANOMA RECURRENT 6 0.0143
29 CORONARY ARTERY INSUFFICIENCY 5 0.0139
30 TIME PERCEPTION ALTERED 5 0.0138
31 TUMOUR LYSIS SYNDROME 121 0.0137
32 WHITE BLOOD CELL COUNT ABNORMAL 87 0.0136
33 GALLBLADDER RUPTURE 5 0.0108
34 ACQUIRED GENE MUTATION 13 0.0099
35 RED BLOOD CELL COUNT ABNORMAL 14 0.0095
36 ABDOMINAL LYMPHADENOPATHY 8 0.0092
37 MALIGNANT TRANSFORMATION 4 0.0089
38 LYMPHATIC DISORDER 5 0.0084
39 MINIMAL RESIDUAL DISEASE 4 0.0083
40 MEAN PLATELET VOLUME INCREASED 5 0.0083
41 ENTEROVIRUS INFECTION 7 0.0081
42 DISSEMINATED CRYPTOCOCCOSIS 6 0.0079
43 HAEMATOLOGICAL INFECTION 19 0.0078
44 NASAL CRUSTING 5 0.0077
45 BLOOD IMMUNOGLOBULIN A DECREASED 5 0.0077
46 HAEMOTHORAX 22 0.0076
47 HAEMORRHAGIC DISORDER 8 0.0074
48 NEUROENDOCRINE CARCINOMA OF THE SKIN 7 0.0072
49 LYMPHOCYTE COUNT INCREASED 23 0.0070
50 GASTROINTESTINAL TOXICITY 32 0.0067
51 IMMUNOGLOBULINS DECREASED 9 0.0066
52 LEUKAEMIA RECURRENT 11 0.0065
53 LYMPHOCYTE COUNT ABNORMAL 7 0.0062
54 HAEMORRHAGIC DIATHESIS 22 0.0062
55 CRYPTOCOCCOSIS 10 0.0061
56 BLOOD IMMUNOGLOBULIN G DECREASED 15 0.0060
57 FULL BLOOD COUNT INCREASED 7 0.0059
58 SPLENOMEGALY 67 0.0057
59 HYPERLEUKOCYTOSIS 5 0.0056
60 WHITE BLOOD CELL DISORDER 15 0.0056
61 PROSTATOMEGALY 22 0.0056
62 PRODUCT MONITORING ERROR 8 0.0055
63 SHOULDER FRACTURE 9 0.0055
64 CARDIOTOXICITY 49 0.0055
65 SPLENIC RUPTURE 9 0.0055
66 POST PROCEDURAL HAEMATOMA 9 0.0053
67 BRAIN STEM HAEMORRHAGE 5 0.0053
68 BLOODY DISCHARGE 6 0.0052
69 DISCOURAGEMENT 12 0.0051
70 PLATELET COUNT ABNORMAL 31 0.0051
71 FUNGAEMIA 8 0.0051
72 WHITE BLOOD CELL COUNT INCREASED 194 0.0051
73 BLOOD IMMUNOGLOBULIN M DECREASED 5 0.0050
74 LYMPHADENOPATHY 176 0.0050
75 APLASIA PURE RED CELL 17 0.0049
76 IMMUNODEFICIENCY 73 0.0049
77 LYMPH NODE PAIN 9 0.0048
78 BLOOD BLISTER 15 0.0048
79 CARDIAC FIBRILLATION 7 0.0048
80 URINARY BLADDER HAEMORRHAGE 10 0.0047
81 ASPERGILLUS INFECTION 31 0.0047
82 BLOOD SODIUM ABNORMAL 5 0.0047
83 FOLLICULAR LYMPHOMA 4 0.0045
84 EAR HAEMORRHAGE 9 0.0044
85 SARCOMA 5 0.0044
86 HAEMORRHAGE URINARY TRACT 11 0.0043
87 HEPATOSPLENOMEGALY 11 0.0043
88 BLOOD CALCIUM ABNORMAL 7 0.0042
89 INVESTIGATION ABNORMAL 6 0.0042
90 IMMUNE THROMBOCYTOPENIA 19 0.0041
91 TYMPANIC MEMBRANE PERFORATION 7 0.0041
92 GASTROINTESTINAL STROMAL TUMOUR 11 0.0041
93 LEUKAEMIA 39 0.0041
94 COCCYDYNIA 6 0.0041
95 FULL BLOOD COUNT ABNORMAL 43 0.0041
96 LYMPHOEDEMA 28 0.0040
97 VERTIGO POSITIONAL 7 0.0040
98 APLASTIC ANAEMIA 20 0.0038
99 HEPATITIS B REACTIVATION 12 0.0038
100 ULCER HAEMORRHAGE 25 0.0037
101 STENOTROPHOMONAS INFECTION 5 0.0037
102 PULMONARY TOXICITY 26 0.0037
103 CONTUSION 351 0.0036
104 PETECHIAE 38 0.0036
105 CARDIAC AMYLOIDOSIS 4 0.0036
106 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
107 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
108 JOINT INSTABILITY 5 0.0036
109 PLATELET DISORDER 9 0.0036
110 PERIPHERAL ARTERY OCCLUSION 5 0.0036
111 SPLEEN DISORDER 6 0.0035
112 AUTOIMMUNE HAEMOLYTIC ANAEMIA 12 0.0035
113 NOROVIRUS INFECTION 5 0.0035
114 BLOOD URIC ACID INCREASED 20 0.0035
115 BLOOD SODIUM DECREASED 65 0.0034
116 RENAL HAEMORRHAGE 7 0.0034
117 DECREASED ACTIVITY 37 0.0034
118 HAEMOGLOBIN ABNORMAL 22 0.0034
119 CARDIAC FLUTTER 22 0.0034
120 PRECANCEROUS SKIN LESION 5 0.0034
121 INTRA-ABDOMINAL FLUID COLLECTION 6 0.0033
122 SQUAMOUS CELL CARCINOMA OF SKIN 20 0.0033
123 HAEMATOCRIT ABNORMAL 4 0.0033
124 LARGE INTESTINE INFECTION 4 0.0033
125 INTRADUCTAL PROLIFERATIVE BREAST LESION 4 0.0032
126 NEUTROPHIL COUNT ABNORMAL 9 0.0032
127 NECK MASS 9 0.0032
128 MALIGNANT NEOPLASM PROGRESSION 325 0.0032
129 INTERNAL HAEMORRHAGE 35 0.0031
130 HAEMATOTOXICITY 29 0.0030
131 ACROCHORDON 4 0.0030
132 LYMPHOMA 46 0.0030
133 ATRIAL FIBRILLATION 288 0.0030
134 CYTOPENIA 36 0.0029
135 CALCULUS BLADDER 4 0.0029
136 BLOOD CHLORIDE INCREASED 5 0.0029
137 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
138 RHINOVIRUS INFECTION 11 0.0028
139 COVID-19 PNEUMONIA 33 0.0028
140 NEPHROLITHIASIS 126 0.0027
141 INJECTION SITE INFECTION 9 0.0027
142 LIMB MASS 6 0.0027
143 ESSENTIAL HYPERTENSION 5 0.0027
144 IMMUNOSUPPRESSION 24 0.0027
145 MIDDLE EAR EFFUSION 6 0.0027
146 RECURRENT CANCER 11 0.0027
147 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
148 LEUKOCYTOSIS 48 0.0026
149 NARCOLEPSY 5 0.0026
150 INTERNATIONAL NORMALISED RATIO ABNORMAL 9 0.0026
151 ABDOMINAL MASS 7 0.0026
152 SUBDURAL HAEMORRHAGE 7 0.0026
153 SKIN CANCER 55 0.0026
154 DEATH 2186 0.0025
155 HAEMATOMA 65 0.0025
156 FULL BLOOD COUNT DECREASED 50 0.0025
157 HAEMATOLOGICAL MALIGNANCY 7 0.0025
158 BLOOD IRON DECREASED 29 0.0024
159 HYPOGAMMAGLOBULINAEMIA 16 0.0024
160 RENAL MASS 5 0.0024
161 ATRIAL FLUTTER 19 0.0024
162 ATRIAL TACHYCARDIA 5 0.0024
163 BLOOD DISORDER 19 0.0024
164 BRAIN ABSCESS 6 0.0024
165 EYE CONTUSION 5 0.0024
166 BLADDER NEOPLASM 4 0.0023
167 ECCHYMOSIS 16 0.0023
168 BLOOD URINE PRESENT 44 0.0023
169 BLOOD PRESSURE ABNORMAL 46 0.0023
170 BRAIN FOG 36 0.0023
171 INFUSION SITE DISCHARGE 4 0.0023
172 LUNG OPACITY 6 0.0023
173 BLOOD POTASSIUM ABNORMAL 6 0.0022
174 AORTIC VALVE STENOSIS 4 0.0022
175 DEMENTIA 62 0.0022
176 HYPERURICAEMIA 9 0.0022
177 CONDUCTION DISORDER 4 0.0022
178 SPINAL STENOSIS 9 0.0022
179 BASAL CELL CARCINOMA 34 0.0022
180 PROSTATIC DISORDER 12 0.0022
181 NEOPLASM 25 0.0022
182 OESOPHAGEAL SPASM 4 0.0022
183 HEART RATE ABNORMAL 12 0.0021
184 PULMONARY OEDEMA 96 0.0021
185 IMMUNE SYSTEM DISORDER 28 0.0021
186 HERNIA 41 0.0021
187 PLEURAL EFFUSION 129 0.0021
188 APPETITE DISORDER 14 0.0021
189 RED BLOOD CELL COUNT DECREASED 60 0.0021
190 PERICARDIAL EFFUSION 48 0.0021
191 BRONCHOPULMONARY ASPERGILLOSIS 16 0.0021
192 LABORATORY TEST ABNORMAL 60 0.0020
193 BLOOD POTASSIUM INCREASED 33 0.0020
194 VENTRICULAR EXTRASYSTOLES 21 0.0020
195 NEUROPATHY PERIPHERAL 192 0.0020
196 CELL DEATH 4 0.0020
197 DEAFNESS UNILATERAL 11 0.0020
198 BONE MARROW DISORDER 6 0.0020
199 CARDIAC DISCOMFORT 4 0.0020
200 HAEMORRHAGE SUBCUTANEOUS 7 0.0020
201 HIP FRACTURE 63 0.0020
202 INCREASED TENDENCY TO BRUISE 18 0.0020
203 MASS 27 0.0019
204 CARDIAC VALVE DISEASE 11 0.0019
205 VENTRICULAR ARRHYTHMIA 7 0.0019
206 DEAFNESS 50 0.0019
207 SKIN ATROPHY 11 0.0019
208 SPINAL FRACTURE 38 0.0019
209 ANAEMIA MACROCYTIC 4 0.0019
210 PNEUMONITIS 51 0.0019
211 VENTRICULAR HYPOKINESIA 6 0.0019
212 COMPRESSION FRACTURE 10 0.0019
213 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
214 PROTEIN TOTAL DECREASED 7 0.0019
215 BLOOD SODIUM INCREASED 5 0.0019
216 INFUSION SITE BRUISING 4 0.0019
217 SUBDURAL HAEMATOMA 26 0.0018
218 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
219 ANEURYSM 9 0.0018
220 HAEMORRHAGE 187 0.0018
221 HAEMOLYTIC ANAEMIA 16 0.0018
222 METASTASES TO SPINE 6 0.0018
223 ADENOCARCINOMA 4 0.0018
224 DRUG TOLERANCE DECREASED 5 0.0018
225 PRODUCT DOSE OMISSION ISSUE 522 0.0018
226 PNEUMONIA FUNGAL 7 0.0018
227 PLATELET COUNT DECREASED 189 0.0018
228 METASTASES TO MENINGES 4 0.0018
229 EAR DISORDER 8 0.0017
230 PULMONARY MASS 26 0.0017
231 MUSCLE HAEMORRHAGE 7 0.0017
232 ONYCHOCLASIS 12 0.0017
233 BLOOD CREATININE ABNORMAL 6 0.0017
234 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
235 ARTHRITIS INFECTIVE 8 0.0017
236 MALIGNANT MELANOMA 23 0.0017
237 PULMONARY PAIN 5 0.0017
238 CATARACT 102 0.0017
239 ORAL SURGERY 4 0.0017
240 BLOOD TEST ABNORMAL 24 0.0017
241 ESCHERICHIA BACTERAEMIA 4 0.0017
242 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 10 0.0017
243 HAEMOLYSIS 13 0.0017
244 ATYPICAL PNEUMONIA 5 0.0017
245 PULMONARY CONGESTION 22 0.0017
246 MYELOFIBROSIS 5 0.0017
247 LYMPHADENITIS 4 0.0017
248 CAROTID ARTERY OCCLUSION 6 0.0016
249 PROSTATITIS 5 0.0016
250 MOUTH HAEMORRHAGE 12 0.0016
251 BONE MARROW FAILURE 33 0.0016
252 HYPERVOLAEMIA 8 0.0016
253 CARDIAC DYSFUNCTION 6 0.0016
254 INFREQUENT BOWEL MOVEMENTS 4 0.0016
255 HAEMOGLOBIN DECREASED 164 0.0016
256 MELANOCYTIC NAEVUS 7 0.0016
257 APPENDICITIS PERFORATED 4 0.0016
258 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
259 PANCYTOPENIA 86 0.0015
260 PROCEDURAL HAEMORRHAGE 6 0.0015
261 DISEASE COMPLICATION 7 0.0015
262 NEAR DEATH EXPERIENCE 5 0.0015
263 RENAL CYST 12 0.0015
264 RENAL FUNCTION TEST ABNORMAL 7 0.0015
265 RIB FRACTURE 31 0.0015
266 GLAUCOMA 29 0.0015
267 SKIN DISCOLOURATION 69 0.0015
268 CEREBRAL HAEMATOMA 5 0.0015
269 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
270 GOUT 26 0.0014
271 MACULAR DEGENERATION 17 0.0014
272 CARDIAC DISORDER 132 0.0014
273 HAEMORRHAGIC STROKE 11 0.0014
274 COVID-19 247 0.0014
275 FLUID INTAKE REDUCED 7 0.0014
276 THROMBOCYTOPENIA 156 0.0014
277 DISEASE PROGRESSION 165 0.0014
278 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
279 BONE CANCER 6 0.0014
280 ADENOVIRUS INFECTION 4 0.0014
281 BILIARY COLIC 4 0.0014
282 WHITE BLOOD CELL COUNT DECREASED 149 0.0014
283 SINUS DISORDER 27 0.0014
284 PURPURA 12 0.0014
285 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
286 ARTHROPOD BITE 10 0.0013
287 IRON DEFICIENCY 6 0.0013
288 URINARY TRACT DISORDER 6 0.0013
289 HEPATITIS B 8 0.0013
290 RENAL IMPAIRMENT 110 0.0013
291 CARDIAC FAILURE 105 0.0013
292 MASTICATION DISORDER 4 0.0013
293 HYPERTRANSAMINASAEMIA 9 0.0013
294 CHEILITIS 7 0.0013
295 ATRIOVENTRICULAR BLOCK 10 0.0013
296 CYST 16 0.0013
297 FAECES HARD 5 0.0013
298 DRUG RESISTANCE 33 0.0013
299 SQUAMOUS CELL CARCINOMA 12 0.0013
300 VENTRICULAR TACHYCARDIA 21 0.0013
301 NON-CARDIAC CHEST PAIN 4 0.0013
302 HEAD INJURY 40 0.0013
303 CARDIAC TAMPONADE 6 0.0013
304 BLOOD CALCIUM INCREASED 11 0.0013
305 ARRHYTHMIA 59 0.0012
306 GINGIVAL BLEEDING 17 0.0012
307 RENAL DISORDER 58 0.0012
308 WEIGHT FLUCTUATION 13 0.0012
309 ORGAN FAILURE 5 0.0012
310 FRUSTRATION TOLERANCE DECREASED 10 0.0012
311 NOCTURIA 15 0.0012
312 RENAL CELL CARCINOMA 6 0.0012
313 POLYP 8 0.0012
314 TRANSIENT ISCHAEMIC ATTACK 41 0.0012
315 ANAEMIA 231 0.0012
316 PERIPHERAL SWELLING 186 0.0012
317 ACUTE CORONARY SYNDROME 10 0.0012
318 ILLNESS 124 0.0012
319 SKIN DISORDER 40 0.0012
320 SKIN MASS 8 0.0012
321 CYTOKINE RELEASE SYNDROME 24 0.0012
322 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
323 THROMBOSIS 96 0.0012
324 PULMONARY THROMBOSIS 13 0.0012
325 PERICARDITIS 20 0.0012
326 ATTENTION DEFICIT HYPERACTIVITY DISORDER 5 0.0012
327 BRONCHIECTASIS 8 0.0012
328 FALL 395 0.0012
329 AGRANULOCYTOSIS 22 0.0012
330 THROAT CANCER 5 0.0012
331 NEOPLASM RECURRENCE 4 0.0012
332 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
333 NEUTROPENIA 160 0.0012
334 HEPATIC CYTOLYSIS 15 0.0012
335 CARDIAC FAILURE CHRONIC 5 0.0012
336 RASH MACULAR 41 0.0012
337 BACK DISORDER 19 0.0012
338 DEHYDRATION 155 0.0012
339 METASTATIC NEOPLASM 5 0.0012
340 BLOOD MAGNESIUM DECREASED 10 0.0012
341 LOCALISED INFECTION 28 0.0012
342 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
343 HEPATIC LESION 5 0.0012
344 PELVIC FRACTURE 9 0.0012
345 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
346 CEREBRAL HAEMORRHAGE 41 0.0011
347 BLOOD LACTIC ACID INCREASED 6 0.0011
348 MENISCUS INJURY 7 0.0011
349 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
350 INFECTION 162 0.0011
351 MYALGIA 188 0.0011
352 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
353 ABNORMAL FAECES 9 0.0011
354 CUTANEOUS VASCULITIS 4 0.0011
355 ESCHERICHIA INFECTION 9 0.0011
356 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 9 0.0011
357 ORAL DISORDER 8 0.0011
358 ISCHAEMIA 5 0.0011
359 SECOND PRIMARY MALIGNANCY 9 0.0011
360 PRODUCT DISTRIBUTION ISSUE 10 0.0011
361 ANGINA UNSTABLE 7 0.0011
362 SKIN REACTION 15 0.0011
363 GALLBLADDER DISORDER 19 0.0011
364 PERIORBITAL SWELLING 6 0.0011
365 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
366 PAROSMIA 8 0.0011
367 CORONAVIRUS INFECTION 7 0.0011
368 FACE INJURY 4 0.0011
369 INTENTIONAL DOSE OMISSION 30 0.0011
370 CARDIAC FAILURE ACUTE 7 0.0010
371 PSEUDOMONAS INFECTION 9 0.0010
372 HEADACHE 657 0.0010
373 TERMINAL STATE 7 0.0010
374 PNEUMONIA 337 0.0010
375 MUSCLE STRAIN 9 0.0010
376 CARDIAC MURMUR 9 0.0010
377 FEBRILE NEUTROPENIA 69 0.0010
378 MOUTH SWELLING 6 0.0010
379 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
380 FEEDING DISORDER 21 0.0010
381 NIGHT SWEATS 33 0.0010
382 FLUID RETENTION 52 0.0010
383 THERAPY CHANGE 10 0.0010
384 ENERGY INCREASED 6 0.0010
385 ANGINA PECTORIS 29 0.0010
386 SKIN LACERATION 11 0.0010
387 PNEUMOTHORAX 16 0.0010
388 CHOLECYSTITIS 12 0.0010
389 EMOTIONAL DISORDER 31 0.0010
390 BRAIN INJURY 10 0.0010
391 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
392 CORONARY ARTERY STENOSIS 5 0.0010
393 LOWER LIMB FRACTURE 19 0.0010
394 INGUINAL HERNIA 6 0.0010
395 DIABETES MELLITUS 75 0.0010
396 HAEMATOCHEZIA 54 0.0010
397 LIVER FUNCTION TEST INCREASED 21 0.0010
398 HYPOACUSIS 42 0.0010
399 EYE HAEMORRHAGE 13 0.0010
400 GASTROOESOPHAGEAL REFLUX DISEASE 78 0.0010
401 AORTIC DISSECTION 4 0.0010
402 MICTURITION URGENCY 11 0.0010
403 FAECES SOFT 7 0.0010
404 SERUM FERRITIN INCREASED 5 0.0009
405 BUNDLE BRANCH BLOCK LEFT 4 0.0009
406 SCIATICA 15 0.0009
407 BONE PAIN 55 0.0009
408 LIMB DISCOMFORT 29 0.0009
409 ACUTE RESPIRATORY FAILURE 18 0.0009
410 MYOCARDIAL INFARCTION 163 0.0009
411 HYPOMAGNESAEMIA 13 0.0009
412 CARDIAC FAILURE CONGESTIVE 75 0.0009
413 BLINDNESS 38 0.0009
414 FATIGUE 725 0.0009
415 CARPAL TUNNEL SYNDROME 13 0.0009
416 TROPONIN INCREASED 7 0.0009
417 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
418 WRIST FRACTURE 11 0.0009
419 DECREASED IMMUNE RESPONSIVENESS 9 0.0009
420 LIGAMENT SPRAIN 9 0.0009
421 NEUTROPHIL COUNT DECREASED 37 0.0009
422 HAEMATOCRIT DECREASED 18 0.0009
423 BLOOD CREATINE INCREASED 4 0.0009
424 UPPER LIMB FRACTURE 18 0.0009
425 GASTRIC ULCER HAEMORRHAGE 5 0.0009
426 DRUG INTOLERANCE 87 0.0009
427 VENTRICULAR FIBRILLATION 10 0.0009
428 HYPERTHYROIDISM 13 0.0009
429 BLOOD POTASSIUM DECREASED 27 0.0009
430 GASTRIC ULCER 17 0.0009
431 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
432 ANAL INCONTINENCE 8 0.0009
433 CEREBROVASCULAR ACCIDENT 150 0.0009
434 NEOPLASM MALIGNANT 59 0.0009
435 LIMB INJURY 24 0.0009
436 GINGIVAL PAIN 7 0.0009
437 BLOOD TESTOSTERONE DECREASED 6 0.0009
438 HAEMOGLOBIN INCREASED 4 0.0009
439 ABDOMINAL HERNIA 4 0.0009
440 LUMBAR VERTEBRAL FRACTURE 4 0.0009
441 RETINAL DETACHMENT 8 0.0009
442 ENCEPHALITIS 6 0.0009
443 OEDEMA 47 0.0009
444 ELECTROLYTE IMBALANCE 10 0.0009
445 HAEMOPTYSIS 24 0.0009
446 SHOCK HAEMORRHAGIC 7 0.0009
447 GASTRITIS EROSIVE 4 0.0009
448 LUNG DISORDER 42 0.0009
449 CELLULITIS 43 0.0009
450 FOOT FRACTURE 16 0.0008
451 NODULE 11 0.0008
452 BLOOD PRESSURE DECREASED 56 0.0008
453 RETINAL HAEMORRHAGE 6 0.0008
454 METASTASIS 6 0.0008
455 NEUTROPENIC SEPSIS 6 0.0008
456 POLLAKIURIA 35 0.0008
457 URINARY RETENTION 28 0.0008
458 HYPOTENSION 168 0.0008
459 ASTHENIA 314 0.0008
460 BACK INJURY 9 0.0008
461 GUILLAIN-BARRE SYNDROME 4 0.0008
462 DIZZINESS POSTURAL 8 0.0008
463 INTESTINAL OBSTRUCTION 31 0.0008
464 GASTROINTESTINAL PAIN 9 0.0008
465 INCORRECT DOSAGE ADMINISTERED 4 0.0008
466 PHARYNGEAL SWELLING 8 0.0008
467 MUSCULOSKELETAL DISCOMFORT 14 0.0008
468 SMALL INTESTINAL OBSTRUCTION 10 0.0008
469 HYPERCALCAEMIA 10 0.0008
470 PIGMENTATION DISORDER 5 0.0008
471 ACUTE HEPATIC FAILURE 11 0.0008
472 HAEMORRHAGE INTRACRANIAL 12 0.0008
473 DRUG INTERACTION 127 0.0008
474 PROSTATIC SPECIFIC ANTIGEN INCREASED 11 0.0008
475 CHROMATURIA 18 0.0008
476 HEART RATE IRREGULAR 18 0.0008
477 HEAD DISCOMFORT 14 0.0008
478 LIVER DISORDER 35 0.0008
479 EPISTAXIS 59 0.0008
480 DYSLIPIDAEMIA 4 0.0008
481 BOWEL MOVEMENT IRREGULARITY 6 0.0008
482 ACUTE MYOCARDIAL INFARCTION 23 0.0008
483 BLINDNESS UNILATERAL 11 0.0008
484 EAR DISCOMFORT 8 0.0008
485 SEASONAL ALLERGY 11 0.0008
486 URINARY TRACT INFECTION 132 0.0008
487 LOSS OF CONSCIOUSNESS 99 0.0008
488 DYSPNOEA EXERTIONAL 29 0.0008
489 HERPES SIMPLEX 5 0.0008
490 PULMONARY HAEMORRHAGE 6 0.0008
491 PLATELET COUNT INCREASED 10 0.0008
492 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 40 0.0008
493 MULTIPLE ALLERGIES 6 0.0008
494 DYSPEPSIA 75 0.0008
495 BRAIN NEOPLASM 7 0.0008
496 HAEMATURIA 26 0.0008
497 IRON DEFICIENCY ANAEMIA 7 0.0008
498 ULCER 12 0.0008
499 BALANCE DISORDER 65 0.0008
500 CARDIOVASCULAR DISORDER 19 0.0007
501 ASCITES 22 0.0007
502 FOOD POISONING 4 0.0007
503 FLANK PAIN 7 0.0007
504 HYPERTENSION 158 0.0007
505 QUALITY OF LIFE DECREASED 10 0.0007
506 MUSCLE DISORDER 6 0.0007
507 SEPTIC SHOCK 32 0.0007
508 CORONARY ARTERY OCCLUSION 10 0.0007
509 MELAENA 16 0.0007
510 CYTOMEGALOVIRUS INFECTION 12 0.0007
511 INSURANCE ISSUE 11 0.0007
512 RASH MACULO-PAPULAR 16 0.0007
513 HYPERTENSIVE CRISIS 8 0.0007
514 NECROSIS 4 0.0007
515 SEPSIS 80 0.0007
516 DEVICE RELATED INFECTION 11 0.0007
517 THYROID DISORDER 11 0.0007
518 SKIN INFECTION 8 0.0007
519 HEART RATE DECREASED 25 0.0007
520 PAPULE 5 0.0007
521 REBOUND EFFECT 8 0.0007
522 MITRAL VALVE INCOMPETENCE 8 0.0007
523 THERAPY PARTIAL RESPONDER 11 0.0007
524 INTERSTITIAL LUNG DISEASE 34 0.0007
525 NEUROLOGICAL SYMPTOM 4 0.0007
526 THERAPY INTERRUPTED 50 0.0007
527 PRODUCT USE COMPLAINT 11 0.0007
528 NECK PAIN 39 0.0007
529 ABDOMINAL DISCOMFORT 117 0.0007
530 HIATUS HERNIA 9 0.0007
531 EXERCISE TOLERANCE DECREASED 4 0.0007
532 PYREXIA 240 0.0007
533 FAECES DISCOLOURED 15 0.0007
534 CYSTITIS 22 0.0007
535 TASTE DISORDER 14 0.0007
536 SYNCOPE 69 0.0007
537 DRY THROAT 7 0.0007
538 DIARRHOEA 443 0.0007
539 GASTRITIS 18 0.0007
540 HYPOVOLAEMIA 4 0.0007
541 DRUG ERUPTION 12 0.0007
542 TOXICITY TO VARIOUS AGENTS 114 0.0007
543 ARTHRITIS 53 0.0007
544 TRANSFUSION 7 0.0007
545 BLOOD PRESSURE FLUCTUATION 16 0.0007
546 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
547 PHOTOSENSITIVITY REACTION 11 0.0007
548 HYPOPHAGIA 17 0.0007
549 BACK PAIN 154 0.0007
550 RENAL PAIN 7 0.0007
551 GAIT INABILITY 22 0.0007
552 NEURALGIA 16 0.0007
553 BODY HEIGHT DECREASED 7 0.0007
554 PNEUMONIA BACTERIAL 6 0.0007
555 ABNORMAL DREAMS 18 0.0007
556 UROSEPSIS 6 0.0006
557 POOR QUALITY SLEEP 14 0.0006
558 NERVE COMPRESSION 6 0.0006
559 PRODUCTIVE COUGH 31 0.0006
560 CHEST PAIN 120 0.0006
561 GENERALISED OEDEMA 8 0.0006
562 ANKLE FRACTURE 10 0.0006
563 HERPES ZOSTER 37 0.0006
564 ARTHRALGIA 266 0.0006
565 HEPATIC CIRRHOSIS 12 0.0006
566 MUSCLE SPASMS 117 0.0006
567 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
568 GASTROINTESTINAL DISORDER 57 0.0006
569 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
570 BRAIN OEDEMA 8 0.0006
571 PALPITATIONS 74 0.0006
572 ORTHOSTATIC HYPOTENSION 11 0.0006
573 AMNESIA 41 0.0006
574 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
575 PULMONARY FIBROSIS 12 0.0006
576 ORAL PAIN 14 0.0006
577 ENTERITIS 4 0.0006
578 HYPOXIA 22 0.0006
579 VERTIGO 38 0.0006
580 OXYGEN SATURATION DECREASED 35 0.0006
581 LYMPHOCYTE COUNT DECREASED 11 0.0006
582 MYELODYSPLASTIC SYNDROME 9 0.0006
583 DYSPNOEA 352 0.0006
584 DYSPHAGIA 59 0.0006
585 HEART RATE INCREASED 61 0.0006
586 DECUBITUS ULCER 5 0.0006
587 HEPATOMEGALY 6 0.0006
588 GASTROENTERITIS VIRAL 11 0.0006
589 SKIN HAEMORRHAGE 9 0.0006
590 SARS-COV-2 TEST POSITIVE 8 0.0006
591 SPINAL COMPRESSION FRACTURE 5 0.0006
592 EMBOLISM 5 0.0006
593 VASCULITIS 7 0.0006
594 MENINGITIS 4 0.0006
595 BLOOD UREA INCREASED 10 0.0006
596 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
597 TOXIC SKIN ERUPTION 6 0.0006
598 BREAST MASS 4 0.0006
599 EMPHYSEMA 6 0.0006
600 BLOOD COUNT ABNORMAL 9 0.0006
601 INFUSION SITE ERYTHEMA 5 0.0006
602 OEDEMA PERIPHERAL 72 0.0006
603 HEPATITIS 15 0.0006
604 STEVENS-JOHNSON SYNDROME 13 0.0006
605 POLYNEUROPATHY 7 0.0006
606 FRACTURE 11 0.0006
607 RASH 252 0.0006
608 LARGE INTESTINE PERFORATION 4 0.0006
609 EXTRASYSTOLES 4 0.0006
610 FOLLICULITIS 6 0.0006
611 JOINT STIFFNESS 15 0.0006
612 COUGH 160 0.0006
613 ENCEPHALOPATHY 14 0.0006
614 GROIN PAIN 5 0.0006
615 SPINAL OSTEOARTHRITIS 5 0.0006
616 CARDIOMEGALY 7 0.0006
617 BLOOD LACTATE DEHYDROGENASE INCREASED 9 0.0006
618 LUNG INFILTRATION 5 0.0006
619 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
620 PHARYNGITIS 7 0.0006
621 HAEMORRHOIDS 11 0.0006
622 JOINT INJURY 12 0.0006
623 KIDNEY INFECTION 11 0.0006
624 ISCHAEMIC STROKE 10 0.0006
625 DECREASED APPETITE 130 0.0006
626 DIZZINESS 279 0.0006
627 OROPHARYNGEAL DISCOMFORT 5 0.0006
628 OSTEOMYELITIS 10 0.0006
629 BLOOD CREATININE INCREASED 36 0.0006
630 HYPONATRAEMIA 31 0.0005
631 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
632 PANCREATITIS 29 0.0005
633 SKIN LESION 15 0.0005
634 TOOTH FRACTURE 6 0.0005
635 INFUSION SITE PAIN 7 0.0005
636 DENTAL CARIES 6 0.0005
637 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
638 COAGULOPATHY 9 0.0005
639 MALNUTRITION 6 0.0005
640 BACTERIAL INFECTION 10 0.0005
641 APPENDICITIS 5 0.0005
642 DIARRHOEA HAEMORRHAGIC 5 0.0005
643 CANDIDA INFECTION 9 0.0005
644 DEPRESSED MOOD 28 0.0005
645 HEPATIC ENZYME INCREASED 36 0.0005
646 COLITIS 20 0.0005
647 CHOLECYSTECTOMY 6 0.0005
648 TINNITUS 24 0.0005
649 CHILLS 61 0.0005
650 HYPERCHOLESTEROLAEMIA 5 0.0005
651 IMPAIRED HEALING 17 0.0005
652 ATELECTASIS 5 0.0005
653 SINUSITIS 53 0.0005
654 CONCUSSION 4 0.0005
655 DYSURIA 19 0.0005
656 PRODUCT USE ISSUE 97 0.0005
657 UVEITIS 7 0.0005
658 RETCHING 11 0.0005
659 HYPERKALAEMIA 18 0.0005
660 AUTOIMMUNE DISORDER 5 0.0005
661 SWELLING 48 0.0005
662 CHOKING 10 0.0005
663 SLEEP DISORDER 36 0.0005
664 MEMORY IMPAIRMENT 70 0.0005
665 WEIGHT INCREASED 114 0.0005
666 WEIGHT DECREASED 142 0.0005
667 THERAPY CESSATION 26 0.0005
668 HOSPICE CARE 5 0.0005
669 DIVERTICULITIS 14 0.0005
670 BLADDER DISORDER 5 0.0005
671 HUNGER 7 0.0005
672 WOUND 14 0.0005
673 FEELING ABNORMAL 120 0.0005
674 STOMATITIS 30 0.0005
675 PAIN 302 0.0005
676 SUBARACHNOID HAEMORRHAGE 5 0.0005
677 IMPAIRED QUALITY OF LIFE 7 0.0005
678 INFLUENZA 54 0.0005
679 GENERAL PHYSICAL HEALTH DETERIORATION 56 0.0005
680 TACHYCARDIA 43 0.0005
681 HYPERBILIRUBINAEMIA 5 0.0005
682 AGEUSIA 12 0.0005
683 PAIN IN EXTREMITY 141 0.0005
684 CHEST DISCOMFORT 49 0.0005
685 DRUG-INDUCED LIVER INJURY 15 0.0005
686 HAEMATEMESIS 12 0.0005
687 SUDDEN DEATH 5 0.0005
688 MIGRAINE 45 0.0005
689 FACIAL PARALYSIS 4 0.0005
690 IMPAIRED WORK ABILITY 10 0.0005
691 ARTHROPATHY 26 0.0005
692 ROTATOR CUFF SYNDROME 6 0.0005
693 FEELING COLD 13 0.0005
694 CONFUSIONAL STATE 75 0.0005
695 CONSTIPATION 101 0.0005
696 RASH PRURITIC 25 0.0005
697 BIPOLAR DISORDER 5 0.0005
698 BLOOD GLUCOSE DECREASED 22 0.0005
699 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
700 NAIL DISORDER 4 0.0005
701 ASPIRATION 5 0.0005
702 ADVERSE DRUG REACTION 41 0.0005
703 BLOOD GLUCOSE FLUCTUATION 5 0.0005
704 GAIT DISTURBANCE 87 0.0005
705 MENTAL IMPAIRMENT 11 0.0005
706 VIRAL INFECTION 15 0.0005
707 GASTROINTESTINAL INFECTION 4 0.0004
708 TYPE 2 DIABETES MELLITUS 15 0.0004
709 OCULAR DISCOMFORT 5 0.0004
710 RENAL FAILURE 59 0.0004
711 PNEUMONIA ASPIRATION 11 0.0004
712 IMPAIRED GASTRIC EMPTYING 6 0.0004
713 SCAB 5 0.0004
714 PERIPHERAL COLDNESS 6 0.0004
715 TREMOR 72 0.0004
716 BLOOD GLUCOSE ABNORMAL 8 0.0004
717 BRONCHITIS 32 0.0004
718 MENTAL STATUS CHANGES 12 0.0004
719 ACUTE KIDNEY INJURY 66 0.0004
720 ROAD TRAFFIC ACCIDENT 18 0.0004
721 COORDINATION ABNORMAL 6 0.0004
722 POST PROCEDURAL HAEMORRHAGE 5 0.0004
723 THINKING ABNORMAL 8 0.0004
724 ERYTHEMA MULTIFORME 4 0.0004
725 NEPHROPATHY 4 0.0004
726 EYE DISORDER 14 0.0004
727 SKIN ULCER 11 0.0004
728 ARTERIOSCLEROSIS 4 0.0004
729 HALLUCINATION 32 0.0004
730 FLATULENCE 24 0.0004
731 INTENTIONAL PRODUCT MISUSE 37 0.0004
732 RESPIRATORY TRACT INFECTION 11 0.0004
733 CHRONIC KIDNEY DISEASE 32 0.0004
734 GASTROINTESTINAL HAEMORRHAGE 35 0.0004
735 THYROID CANCER 5 0.0004
736 EAR INFECTION 11 0.0004
737 DYSSTASIA 12 0.0004
738 TRANSAMINASES INCREASED 9 0.0004
739 HEPATOTOXICITY 9 0.0004
740 MOBILITY DECREASED 29 0.0004
741 INABILITY TO AFFORD MEDICATION 4 0.0004
742 ABDOMINAL DISTENSION 42 0.0004
743 PROCEDURAL PAIN 11 0.0004
744 CHOLELITHIASIS 13 0.0004
745 CORONARY ARTERY DISEASE 12 0.0004
746 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
747 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 19 0.0004
748 OSTEOPENIA 6 0.0004
749 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
750 HYPOTHERMIA 4 0.0004
751 ILL-DEFINED DISORDER 24 0.0004
752 ABDOMINAL PAIN UPPER 81 0.0004
753 INFUSION RELATED REACTION 26 0.0004
754 FUNGAL INFECTION 13 0.0004
755 SEIZURE 45 0.0004
756 ERECTILE DYSFUNCTION 10 0.0004
757 FEMUR FRACTURE 12 0.0004
758 EJECTION FRACTION DECREASED 6 0.0004
759 BLOOD PRESSURE INCREASED 59 0.0004
760 PULMONARY HYPERTENSION 8 0.0004
761 MUSCULOSKELETAL PAIN 20 0.0004
762 BEDRIDDEN 5 0.0004
763 MOUTH ULCERATION 8 0.0004
764 TOOTH INFECTION 5 0.0004
765 OBESITY 6 0.0004
766 RASH ERYTHEMATOUS 18 0.0004
767 DYSPHONIA 22 0.0004
768 EATING DISORDER 8 0.0004
769 CARDIAC ARREST 31 0.0004
770 MIDDLE INSOMNIA 7 0.0004
771 HEPATIC CANCER 9 0.0004
772 HAIR TEXTURE ABNORMAL 5 0.0004
773 FEAR 10 0.0004
774 MUSCLE TIGHTNESS 6 0.0004
775 PRESYNCOPE 9 0.0004
776 TACHYPNOEA 5 0.0004
777 RESPIRATORY DISORDER 11 0.0004
778 PRODUCT PRESCRIBING ISSUE 8 0.0004
779 CHOLESTASIS 7 0.0004
780 POST PROCEDURAL COMPLICATION 7 0.0004
781 APHASIA 11 0.0004
782 INSOMNIA 97 0.0004
783 STAPHYLOCOCCAL INFECTION 12 0.0004
784 RESPIRATORY ARREST 10 0.0004
785 MALAISE 158 0.0004
786 LEUKOPENIA 18 0.0004
787 ORAL HERPES 7 0.0004
788 NAUSEA 283 0.0004
789 NASAL CONGESTION 21 0.0004
790 INTESTINAL PERFORATION 4 0.0004
791 BLISTER 20 0.0004
792 VISUAL IMPAIRMENT 44 0.0004
793 HEMIPARESIS 6 0.0004
794 PAIN IN JAW 10 0.0004
795 NERVOUS SYSTEM DISORDER 11 0.0004
796 MYOCARDIAL ISCHAEMIA 4 0.0004
797 PARALYSIS 5 0.0003
798 MYOCARDITIS 4 0.0003
799 GASTRIC HAEMORRHAGE 4 0.0003
800 DIPLOPIA 9 0.0003
801 DELIRIUM 12 0.0003
802 HYPERSENSITIVITY 64 0.0003
803 ALOPECIA 67 0.0003
804 OSTEOPOROSIS 14 0.0003
805 LACTIC ACIDOSIS 11 0.0003
806 DEEP VEIN THROMBOSIS 22 0.0003
807 CARDIOMYOPATHY 5 0.0003
808 PERITONITIS 7 0.0003
809 SOMNOLENCE 68 0.0003
810 TOOTH LOSS 7 0.0003
811 BACTERAEMIA 4 0.0003
812 PRURITUS 129 0.0003
813 ACCIDENT 4 0.0003
814 HYPERLIPIDAEMIA 4 0.0003
815 DERMATITIS 7 0.0003
816 JOINT SWELLING 40 0.0003
817 MUSCULOSKELETAL STIFFNESS 29 0.0003
818 ERYTHEMA 68 0.0003
819 OFF LABEL USE 289 0.0003
820 RESTLESS LEGS SYNDROME 6 0.0003
821 RESPIRATORY FAILURE 24 0.0003
822 VISION BLURRED 45 0.0003
823 DEPRESSION 74 0.0003
824 CONJUNCTIVITIS 6 0.0003
825 MUSCULOSKELETAL CHEST PAIN 5 0.0003
826 ILEUS 4 0.0003
827 HEPATIC FUNCTION ABNORMAL 12 0.0003
828 ACUTE MYELOID LEUKAEMIA 5 0.0003
829 PHOTOPHOBIA 6 0.0003
830 DERMATITIS ALLERGIC 4 0.0003
831 VOMITING 149 0.0003
832 MUSCULAR WEAKNESS 36 0.0003
833 LUNG NEOPLASM MALIGNANT 13 0.0003
834 DISEASE RECURRENCE 15 0.0003
835 MUSCULOSKELETAL DISORDER 6 0.0003
836 TOOTH DISORDER 7 0.0003
837 RESPIRATORY TRACT CONGESTION 5 0.0003
838 INCREASED APPETITE 6 0.0003
839 OROPHARYNGEAL PAIN 29 0.0003
840 INTRAOCULAR PRESSURE INCREASED 4 0.0003
841 RASH PAPULAR 7 0.0003
842 THROAT IRRITATION 14 0.0003
843 PANCREATITIS ACUTE 7 0.0003
844 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
845 ERUCTATION 6 0.0003
846 INFLAMMATION 16 0.0003
847 LIVER FUNCTION TEST ABNORMAL 9 0.0003
848 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
849 RHINORRHOEA 20 0.0003
850 NASOPHARYNGITIS 57 0.0003
851 EAR PAIN 6 0.0003
852 PRODUCT AVAILABILITY ISSUE 7 0.0003
853 MUCOSAL INFLAMMATION 8 0.0003
854 MYELOSUPPRESSION 11 0.0003
855 METASTASES TO BONE 5 0.0003
856 URINARY INCONTINENCE 9 0.0003
857 RECTAL HAEMORRHAGE 13 0.0003
858 HEPATIC FAILURE 9 0.0003
859 PROSTATE CANCER 24 0.0003
860 BODY TEMPERATURE INCREASED 6 0.0003
861 DYSARTHRIA 11 0.0003
862 SCAR 5 0.0003
863 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
864 ANXIETY 82 0.0003
865 SPEECH DISORDER 15 0.0003
866 DRY SKIN 38 0.0003
867 LYMPHOPENIA 4 0.0003
868 HYPOTHYROIDISM 9 0.0003
869 DRY EYE 14 0.0003
870 THIRST 5 0.0003
871 DISORIENTATION 11 0.0003
872 TOOTHACHE 5 0.0003
873 HYPOKINESIA 4 0.0003
874 APATHY 4 0.0003
875 GASTROENTERITIS 4 0.0003
876 COMA 13 0.0003
877 UNRESPONSIVE TO STIMULI 7 0.0003
878 LIP SWELLING 9 0.0003
879 SLEEP APNOEA SYNDROME 5 0.0003
880 SHOCK 6 0.0003
881 BLOOD BILIRUBIN INCREASED 7 0.0003
882 DRY MOUTH 21 0.0003
883 HYPOAESTHESIA 38 0.0003
884 OCULAR HYPERAEMIA 12 0.0003
885 PULMONARY EMBOLISM 24 0.0003
886 MOVEMENT DISORDER 8 0.0002
887 PRODUCT PHYSICAL ISSUE 5 0.0002
888 DISCOMFORT 15 0.0002
889 LIVER INJURY 6 0.0002
890 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
891 TREATMENT FAILURE 20 0.0002
892 IRRITABLE BOWEL SYNDROME 5 0.0002
893 IRRITABILITY 14 0.0002
894 URTICARIA 39 0.0002
895 LACRIMATION INCREASED 7 0.0002
896 NEOPLASM PROGRESSION 8 0.0002
897 NEUROTOXICITY 4 0.0002
898 COLD SWEAT 4 0.0002
899 BRADYCARDIA 12 0.0002
900 LETHARGY 13 0.0002
901 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
902 JAUNDICE 6 0.0002
903 SNEEZING 5 0.0002
904 DISTURBANCE IN ATTENTION 12 0.0002
905 CRYING 8 0.0002
906 BONE DISORDER 4 0.0002
907 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
908 SWELLING FACE 14 0.0002
909 COGNITIVE DISORDER 10 0.0002
910 BLOOD GLUCOSE INCREASED 40 0.0002
911 ABDOMINAL PAIN 49 0.0002
912 FIBROMYALGIA 5 0.0002
913 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
914 HOSPITALISATION 30 0.0002
915 HYPOKALAEMIA 9 0.0002
916 ECZEMA 10 0.0002
917 KNEE ARTHROPLASTY 4 0.0002
918 RENAL CANCER 9 0.0002
919 EYE SWELLING 7 0.0002
920 METABOLIC ACIDOSIS 6 0.0002
921 HYPOGLYCAEMIA 9 0.0002
922 MENTAL DISORDER 8 0.0002
923 FEELING HOT 11 0.0002
924 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
925 THERAPY NON-RESPONDER 8 0.0002
926 EYE PAIN 10 0.0002
927 HYPERSOMNIA 5 0.0002
928 MUSCLE TWITCHING 4 0.0002
929 NERVOUSNESS 9 0.0002
930 HYPERHIDROSIS 22 0.0002
931 RENAL INJURY 5 0.0002
932 PRODUCT USE IN UNAPPROVED INDICATION 41 0.0002
933 HYPERGLYCAEMIA 6 0.0002
934 PANIC ATTACK 6 0.0002
935 SUICIDAL IDEATION 15 0.0002
936 CEREBRAL INFARCTION 4 0.0002
937 HOT FLUSH 12 0.0002
938 ACNE 12 0.0002
939 ABDOMINAL PAIN LOWER 4 0.0002
940 GASTRIC CANCER 4 0.0002
941 BURNING SENSATION 11 0.0002
942 MOOD SWINGS 5 0.0002
943 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
944 PARAESTHESIA 24 0.0002
945 BREAST CANCER FEMALE 4 0.0001
946 FREQUENT BOWEL MOVEMENTS 4 0.0001
947 DRUG INEFFECTIVE 194 0.0001
948 ANAPHYLACTIC REACTION 8 0.0001
949 NIGHTMARE 5 0.0001
950 SKIN EXFOLIATION 12 0.0001
951 OSTEOARTHRITIS 6 0.0001
952 CONDITION AGGRAVATED 43 0.0001
953 ADVERSE EVENT 13 0.0001
954 FLUSHING 14 0.0001
955 RESTLESSNESS 5 0.0001
956 COLITIS ULCERATIVE 6 0.0001
957 UNEVALUABLE EVENT 10 0.0001
958 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
959 BLOOD CHOLESTEROL INCREASED 6 0.0001
960 INJURY 9 0.0001
961 BONE DENSITY DECREASED 4 0.0001
962 NO ADVERSE EVENT 23 0.0001
963 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
964 ABNORMAL BEHAVIOUR 5 0.0001
965 ASTHMA 14 0.0001
966 AGITATION 9 0.0001
967 CARDIO-RESPIRATORY ARREST 5 0.0001
968 EYE PRURITUS 4 0.0001
969 GASTRIC DISORDER 4 0.0001
970 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
971 TREATMENT NONCOMPLIANCE 6 0.0001
972 UNDERDOSE 8 0.0001
973 EMOTIONAL DISTRESS 13 0.0001
974 SKIN BURNING SENSATION 7 0.0001
975 INFLUENZA LIKE ILLNESS 8 0.0001
976 RHEUMATOID ARTHRITIS 11 0.0001
977 ANGIOEDEMA 4 0.0001
978 INJECTION SITE BRUISING 7 0.0001
979 BREAST CANCER 8 0.0001
980 WHEEZING 5 0.0001
981 MULTIPLE SCLEROSIS 4 0.0001
982 DYSGEUSIA 6 0.0001
983 INCORRECT DOSE ADMINISTERED 18 0.0001
984 MEDICATION ERROR 4 0.0001
985 BLADDER CANCER 4 0.0001
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
987 OVERDOSE 4 0.0000
988 INJECTION SITE PAIN 4 0.0000